doi: 10.1124/jpet.102.037481
FMI's analysis of the GLP-1 receptor agonist market in Europe consists of country-wise assessment including Germany, United Kingdom, France, Italy, and Spain
How GLP-1 Medications Affect Blood Pressure in Patients with Hypertension Weight loss often leads to a decreased need for blood pressure medications, which can pose risks for patients who are currently on anti-hypertensive medications (blood pressure pills)
There is no benefit to reaching the maximum dose quickly
Patients with decompensated MASH cirrhosis were at an increased risk of all-cause mortality (HR: 52.24, 95% CI 24.28,112.40) followed by compensated MASH cirrhosis (HR: 13.62, 95% CI 6.13,30.29) compared to MASH without cirrhosis (Figure 1c)